Anhui Anke BioTech Group (300009) — Financial Flexibility Index
Anhui Anke BioTech Group (300009) has a Financial Flexibility Index of 0.35x as of September 2025. Free cash flow of CN¥262.14 Million (operating CF CN¥240.51 Million minus capex CN¥21.63 Million) represents 0% of total liabilities (CN¥755.64 Million). Check Anhui Anke BioTech Group (300009) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Anhui Anke BioTech Group Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Anhui Anke BioTech Group across 20 annual periods. For the full cash flow conversion analysis, see 300009 cash flow metrics.
Annual Financial Flexibility Index for Anhui Anke BioTech Group (2006–2025)
Year-by-year free cash flow to debt coverage for Anhui Anke BioTech Group. Explore how well can Anhui Anke BioTech Group service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.22x | CN¥990.11 Million | CN¥863.22 Million | CN¥811.30 Million | ▲ +27.0% |
| 2024 | 0.96x | CN¥802.60 Million | CN¥685.37 Million | CN¥835.41 Million | ▼ -14.8% |
| 2023 | 1.13x | CN¥1.15 Billion | CN¥952.97 Million | CN¥1.02 Billion | ▼ -17.8% |
| 2022 | 1.37x | CN¥1.17 Billion | CN¥698.98 Million | CN¥855.17 Million | ▲ +45.2% |
| 2021 | 0.94x | CN¥723.40 Million | CN¥592.17 Million | CN¥765.52 Million | ▼ -6.0% |
| 2020 | 1.01x | CN¥603.32 Million | CN¥464.80 Million | CN¥600.29 Million | ▲ +9.7% |
| 2019 | 0.92x | CN¥482.10 Million | CN¥295.63 Million | CN¥526.19 Million | ▼ -5.7% |
| 2018 | 0.97x | CN¥501.21 Million | CN¥287.49 Million | CN¥515.86 Million | ▲ +16.3% |
| 2017 | 0.84x | CN¥412.40 Million | CN¥280.63 Million | CN¥493.73 Million | ▲ +37.6% |
| 2016 | 0.61x | CN¥327.18 Million | CN¥258.01 Million | CN¥539.04 Million | ▼ -50.7% |
| 2015 | 1.23x | CN¥155.69 Million | CN¥118.73 Million | CN¥126.48 Million | ▼ -11.1% |
| 2014 | 1.38x | CN¥196.72 Million | CN¥108.68 Million | CN¥142.11 Million | ▲ +45.6% |
| 2013 | 0.95x | CN¥84.85 Million | CN¥53.21 Million | CN¥89.21 Million | ▼ -38.8% |
| 2012 | 1.55x | CN¥113.22 Million | CN¥53.80 Million | CN¥72.91 Million | ▲ +3.5% |
| 2011 | 1.50x | CN¥89.72 Million | CN¥7.18 Million | CN¥59.77 Million | ▲ +72.2% |
| 2010 | 0.87x | CN¥58.61 Million | CN¥47.43 Million | CN¥67.25 Million | ▼ -20.1% |
| 2009 | 1.09x | CN¥51.21 Million | CN¥38.67 Million | CN¥46.95 Million | ▲ +148.9% |
| 2008 | 0.44x | CN¥32.57 Million | CN¥26.04 Million | CN¥74.32 Million | ▼ -1.9% |
| 2007 | 0.45x | CN¥44.42 Million | CN¥35.10 Million | CN¥99.46 Million | ▲ +43.7% |
| 2006 | 0.31x | CN¥32.24 Million | CN¥29.66 Million | CN¥103.72 Million | — |